-
4
-
-
0024358369
-
A rating scale for drug-induced akathisia
-
Barnes TR. A rating scale for drug-induced akathisia. Br J Psychiatry. 1989 ; 154: 672-676 (Pubitemid 19154942)
-
(1989)
British Journal of Psychiatry
, vol.154
, Issue.MAY
, pp. 672-676
-
-
Barnes, T.R.E.1
-
5
-
-
0027475985
-
A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients
-
Chouinard G, Jones B, Remington G, et al. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. J Clin Psychopharmacol. 1993 ; 13: 25-40 (Pubitemid 23030357)
-
(1993)
Journal of Clinical Psychopharmacology
, vol.13
, Issue.1
, pp. 25-40
-
-
Chouinard, G.1
Jones, B.2
Remington, G.3
Bloom, D.4
Addington, D.5
MacEwan, G.W.6
Labelle, A.7
Beauclair, L.8
Arnott, W.9
-
6
-
-
33751209463
-
A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis
-
Crespo-Facorro B, Perez-Iglesias R, Ramirez-Bonilla ML, et al. A practical clinical trial comparing haloperidol, risperidone and olanzapine for the acute treatment of first-episode nonaffective psychosis. J Clin Psychiatry. 2006 ; 67: 1511-1521 (Pubitemid 44787432)
-
(2006)
Journal of Clinical Psychiatry
, vol.67
, Issue.10
, pp. 1511-1521
-
-
Crespo-Facorro, B.1
Perez-Iglesias, R.2
Ramirez-Bonilla, M.3
Martinez-Garcia, O.4
Llorca, J.5
Vazquez-Barquero, J.L.6
-
7
-
-
0033372843
-
Risperidone in the treatment of first-episode psychotic patients: A double-blind multicenter study
-
Emsley RA. Risperidone in the treatment of first-episode psychotic patients: a double-blind multicenter study. Schizophr Bull. 1999 ; 25: 721-729 (Pubitemid 30013554)
-
(1999)
Schizophrenia Bulletin
, vol.25
, Issue.4
, pp. 721-729
-
-
Emsley, R.A.1
-
9
-
-
24344442805
-
The European First Episode Schizophrenia Trial (EUFEST): Rationale and design of the trial
-
DOI 10.1016/j.schres.2005.06.004, PII S0920996405002379
-
Fleischhacker WW, Keet IP, Kahn RS. The European First Episode Schizophrenia Trial (EUFEST): Rationale and design of the trial. Schizophr Res. 2005 ; 78: 147-156 (Pubitemid 41254018)
-
(2005)
Schizophrenia Research
, vol.78
, Issue.2-3
, pp. 147-156
-
-
Fleischhacker, W.W.1
Keet, I.P.M.2
Kahn, R.S.3
Hummer, M.4
Peuskens, J.5
Hranov, L.G.6
Libiger, J.7
Dollfus, S.8
Gaebel, W.9
Davidson, M.10
Galderisi, S.11
Boter, H.12
Rybakowski, J.13
Gheorghe, M.14
Ibor, J.-J.L.15
Sedvall, G.16
Riecher-Rossler, A.17
-
10
-
-
37049001600
-
Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia: 1-Year results of a randomized controlled trial within the German Research Network on Schizophrenia
-
Gaebel W, Riesbeck M, Wölwer W, et al. Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia: 1-year results of a randomized controlled trial within the German Research Network on Schizophrenia. J Clin Psychiatry. 2007 ; 68: 1763-1774 (Pubitemid 350247506)
-
(2007)
Journal of Clinical Psychiatry
, vol.68
, Issue.11
, pp. 1763-1774
-
-
Gaebel, W.1
Riesbeck, M.2
Wolwer, W.3
Klimke, A.4
Eickhoff, M.5
Von Wilmsdorff, M.6
Jockers-Scherubl, M.C.7
Kuhn, K.-U.8
Lemke, M.9
Bechdolf, A.10
Bender, S.11
Degner, D.12
Schlosser, R.13
Schmidt, L.G.14
Schmitt, A.15
Jager, M.16
Buchkremer, G.17
Falkai, P.18
Klingberg, S.19
Kopcke, W.20
Maier, W.21
Hafner, H.22
Ohmann, C.23
Salize, H.J.24
Schneider, F.25
Moller, H.-J.26
more..
-
11
-
-
33747398701
-
Olanzapine and haloperidol in first episode psychosis: Two-year data
-
DOI 10.1016/j.schres.2006.06.021, PII S0920996406002945
-
Green AI, Lieberman JA, Hamer RM, et al. Olanzapine and haloperidol in first episode psychosis: two-year data. Schizophr Res. 2006 ; 86: 234-243 (Pubitemid 44251272)
-
(2006)
Schizophrenia Research
, vol.86
, Issue.1-3
, pp. 234-243
-
-
Green, A.I.1
Lieberman, J.A.2
Hamer, R.M.3
Glick, I.D.4
Gur, R.E.5
Kahn, R.S.6
McEvoy, J.P.7
Perkins, D.O.8
Rothschild, A.J.9
Sharma, T.10
Tohen, M.F.11
Woolson, S.12
Zipursky, R.B.13
-
13
-
-
0029903855
-
The World Health Organization Short Disability Assessment Schedule (WHO DAS-S): A tool for the assessment of difficulties in selected areas of functioning of patients with mental disorders
-
DOI 10.1007/BF00783424
-
Janca A, Kastrup M, Katschnig H, et al. The World Health Organization Short Disability Assessment Schedule (WHO DAS-S): a tool for the assessment of difficulties in selected areas of functioning of patients with mental disorders. Soc Psychiatry Psychiatr Epidemiol. 1996 ; 31: 349-354 (Pubitemid 26362865)
-
(1996)
Social Psychiatry and Psychiatric Epidemiology
, vol.31
, Issue.6
, pp. 349-354
-
-
Janca, A.1
Kastrup, M.2
Katschnig, H.3
Lopez-Ibor Jr., J.J.4
Mezzich, J.E.5
Sartorius, N.6
-
14
-
-
40949142200
-
Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: An open randomised clinical trial
-
DOI 10.1016/S0140-6736(08)60486-9, PII S0140673608604869
-
Kahn RS, Fleischhacker WW, Boter H, et al. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. Lancet. 2008 ; 371: 1085-1097 (Pubitemid 351418005)
-
(2008)
The Lancet
, vol.371
, Issue.9618
, pp. 1085-1097
-
-
Kahn, R.S.1
Fleischhacker, W.W.2
Boter, H.3
Davidson, M.4
Vergouwe, Y.5
Keet, I.P.6
Gheorghe, M.D.7
Rybakowski, J.K.8
Galderisi, S.9
Libiger, J.10
Hummer, M.11
Dollfus, S.12
Lopez-Ibor, J.J.13
Hranov, L.G.14
Gaebel, W.15
Peuskens, J.16
Lindefors, N.17
Riecher-Rossler, A.18
Grobbee, D.E.19
-
15
-
-
20544458079
-
First-episode schizophrenia: A focus on pharmacological treatment and safety considerations
-
DOI 10.2165/00003495-200565080-00006
-
Kelly DL, Conley RR, Carpenter WT. First-episode schizophrenia. A focus on pharmacological treatment and safety considerations. Drugs. 2005 ; 65: 1113-1138 (Pubitemid 40840008)
-
(2005)
Drugs
, vol.65
, Issue.8
, pp. 1113-1138
-
-
Kelly, D.L.1
Conley, R.R.2
Carpenter, W.T.3
-
16
-
-
0033521616
-
Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials
-
DOI 10.1016/S0920-9964(98)00105-4, PII S0920996498001054
-
Leucht S, Pitschel-Walz G, Abraham D, et al. Efficacy and extrapyramidal side effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo: a meta-analysis of randomised controlled trials. Schizophr Res. 1999 ; 35: 51-68 (Pubitemid 29023554)
-
(1999)
Schizophrenia Research
, vol.35
, Issue.1
, pp. 51-68
-
-
Leucht, S.1
Pitschel-Walz, G.2
Abraham, D.3
Kissling, W.4
-
17
-
-
0029977951
-
Atypical antipsychotic drugs as a first-line treatment of schizophrenia: A rationale and hypothesis
-
Lieberman JA. Atypical antipsychotic drugs as a first-line treatment of schizophrenia: rationale and hypothesis. J Clin Psychiatry. 1996 ; 57 (Suppl 11). 68-71 (Pubitemid 26389788)
-
(1996)
Journal of Clinical Psychiatry
, vol.57
, Issue.SUPPL. 11
, pp. 68-71
-
-
Lieberman, J.A.1
-
18
-
-
0042882529
-
Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: A randomized, double-blind trial of olanzapine versus haloperidol
-
DOI 10.1176/appi.ajp.160.8.1396
-
Lieberman JA, Tollefson G, Tohen M, et al. Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol. Am J Psychiatry. 2003 ; 160: 1396-1404 (Pubitemid 41070913)
-
(2003)
American Journal of Psychiatry
, vol.160
, Issue.8
, pp. 1396-1404
-
-
Lieberman, J.A.1
Tollefson, G.2
Tohen, M.3
Green, A.I.4
Gur, R.E.5
Kahn, R.6
McEvoy, J.7
Perkins, D.8
Sharma, T.9
Zipursky, R.10
Wei, H.11
Hamer, R.M.12
-
19
-
-
0023244845
-
The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients
-
Lingjarde O, Ahlfors UG, Bech P, et al. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and cross sectional study of side effects in antipsychotic-treated patients. Acta Psychiatr Scand Suppl. 1987 ; 334: 1-100 (Pubitemid 17115352)
-
(1987)
Acta Psychiatrica Scandinavica
, vol.76
, Issue.1 SUPPL. 334
, pp. 1-100
-
-
Lingjaerde, O.1
Ahlfors, U.G.2
Bech, P.3
-
20
-
-
0026410773
-
Optimal dose of antipsychotics in acute schizophrenia: A controlled study of the antipsychotic threshold and higher haloperidol dose
-
McEvoy JP, Hogarty GE, Steingard S. Optimal dose of antipsychotics in acute schizophrenia: a controlled study of the antipsychotic threshold and higher haloperidol dose. Arch Gen Psychiatry. 1991 ; 48: 739-745
-
(1991)
Arch Gen Psychiatry
, vol.48
, pp. 739-745
-
-
McEvoy, J.P.1
Hogarty, G.E.2
Steingard, S.3
-
21
-
-
34547218869
-
Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: A randomized, double-blind 52-week comparison
-
DOI 10.1176/appi.ajp.164.7.1050
-
McEvoy JP, Lieberman JA, Perkins DO, et al. Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison. Am J Psychiatry. 2007 ; 164: 1050-1060 (Pubitemid 47121394)
-
(2007)
American Journal of Psychiatry
, vol.164
, Issue.7
, pp. 1050-1060
-
-
McEvoy, J.P.1
Lieberman, J.A.2
Perkins, D.O.3
Hamer, R.M.4
Gu, H.5
Lazarus, A.6
Sweitzer, D.7
Olexy, C.8
Weiden, P.9
Strakowski, S.D.10
-
22
-
-
18744396959
-
The case for practical clinical trials in psychiatry
-
DOI 10.1176/appi.ajp.162.5.836
-
March JS, Silva SG, Compton S, et al. The case for practical clinical trials in psychiatry. Am J Psychiatry. 2005 ; 162: 836-846 (Pubitemid 40676194)
-
(2005)
American Journal of Psychiatry
, vol.162
, Issue.5
, pp. 836-846
-
-
March, J.S.1
Silva, S.G.2
Compton, S.3
Shapiro, M.4
Califf, R.5
Krishnan, R.6
-
23
-
-
0028342655
-
Risperidone in the treatment of schizophrenia
-
Marder SR, Meibach RC. Risperidone in the treatment of schizophrenia. Am J Psychiatry 1994;. 1994 ; 151: 825-835
-
(1994)
Am J Psychiatry 1994;
, vol.151
, pp. 825-835
-
-
Marder, S.R.1
Meibach, R.C.2
-
24
-
-
0021951973
-
The Modified Hamilton Rating Scale for Depression: Reliability and validity
-
DOI 10.1016/0165-1781(85)90057-5
-
Miller IW, Bishop S, Norman WH, et al. The modified Hamilton Rating Scale for Depression: reliability and validity. Psychiatry Res. 1985 ; 14: 131-142 (Pubitemid 15138581)
-
(1985)
Psychiatry Research
, vol.14
, Issue.2
, pp. 131-142
-
-
Miller, I.W.1
Bishop, S.2
Norman, W.H.3
Maddever, H.4
-
25
-
-
69949087539
-
Atypical antipsychotic augmentation in major depressive disorder: A meta-analysis of placebo-controlled randomized trials
-
Nelson JC, Papakostas GI. Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials. Am J Psychiatry. 2009 ; 166: 980-991
-
(2009)
Am J Psychiatry
, vol.166
, pp. 980-991
-
-
Nelson, J.C.1
Papakostas, G.I.2
-
26
-
-
0000503515
-
The brief psychiatric rating scale
-
Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep. 1962 ; 10: 799-812
-
(1962)
Psychol Rep
, vol.10
, pp. 799-812
-
-
Overall, J.E.1
Gorham, D.R.2
-
27
-
-
65249188795
-
Epidemiological factors associated with treated incidence of first-episode non-affective psychosis in Cantabria: Insights from the PAFIP
-
Pelayo-Terán JM, Pérez-Iglesias R, Ramírez-Bonilla M, et al. Epidemiological factors associated with treated incidence of first-episode non-affective psychosis in Cantabria: insights from the PAFIP. Early Intervention in Psychiatry. 2008 ; 2: 178-187
-
(2008)
Early Intervention in Psychiatry
, vol.2
, pp. 178-187
-
-
Pelayo-Terán, J.M.1
Pérez-Iglesias, R.2
Ramírez-Bonilla, M.3
-
28
-
-
39149089276
-
Weight gain induced by haloperidol, risperidone and olanzapine after 1"year: Findings of a randomized clinical trial in a drug-nai"ve population
-
DOI 10.1016/j.schres.2007.10.022, PII S0920996407004677
-
Perez-Iglesias R, Crespo-Facorro B, Martinez-Garcia O, et al. Weight gain induced by haloperidol, risperidone and olanzapine after 1 year: findings of a randomized clinical trial in a drug-naïve population. Schizophr Res. 2008a ; 99: 13-22 (Pubitemid 351255577)
-
(2008)
Schizophrenia Research
, vol.99
, Issue.1-3
, pp. 13-22
-
-
Perez-Iglesias, R.1
Crespo-Facorro, B.2
Martinez-Garcia, O.3
Ramirez-Bonilla, M.L.4
Alvarez-Jimenez, M.5
Pelayo-Teran, J.M.6
Garcia-Unzueta, M.T.7
Amado, J.A.8
Vazquez-Barquero, J.L.9
-
29
-
-
51449088481
-
Effect of antipsychotics on peptides involved in energy balance in drug-naive psychotic patients after 1 year of treatment
-
Perez-Iglesias R, Vazquez-Barquero JL, Amado JA, et al. Effect of antipsychotics on peptides involved in energy balance in drug-naive psychotic patients after 1 year of treatment. J Clin Psychopharmacol. 2008b ; 28: 289-295
-
(2008)
J Clin Psychopharmacol
, vol.28
, pp. 289-295
-
-
Perez-Iglesias, R.1
Vazquez-Barquero, J.L.2
Amado, J.A.3
-
30
-
-
58249129947
-
Glucose and lipid disturbances after 1 year of antipsychotic treatment in a drug-naïve population
-
Perez-Iglesias R, Mata I, Pelayo-Teran JM, et al. Glucose and lipid disturbances after 1 year of antipsychotic treatment in a drug-naïve population. Schizophr Res. 2009 ; 107: 115-121
-
(2009)
Schizophr Res
, vol.107
, pp. 115-121
-
-
Perez-Iglesias, R.1
Mata, I.2
Pelayo-Teran, J.M.3
-
31
-
-
0032921705
-
Olanzapine versus haloperidol treatment in first-episode psychosis
-
Sanger TM, Lieberman JA, Tohen M, et al. Olanzapine versus haloperidol treatment in first-episode psychosis. Am J Psychiatry. 1999 ; 156: 79-87 (Pubitemid 29034883)
-
(1999)
American Journal of Psychiatry
, vol.156
, Issue.1
, pp. 79-87
-
-
Sanger, T.M.1
Lieberman, J.A.2
Tohen, M.3
Grundy, S.4
Beasley Jr., C.5
Tollefson, G.D.6
-
32
-
-
21044457943
-
Risperidone and haloperidol in first-episode psychosis: A long-term randomized trial
-
DOI 10.1176/appi.ajp.162.5.947
-
Schooler N, Rabinowitz J, Davidson M, et al. Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial. Am J Psychiatry. 2005 ; 162: 947-953 (Pubitemid 40676208)
-
(2005)
American Journal of Psychiatry
, vol.162
, Issue.5
, pp. 947-953
-
-
Schooler, N.1
Rabinowitz, J.2
Davidson, M.3
Emsley, R.4
Harvey, P.D.5
Kopala, L.6
McGorry, P.D.7
Van Hove, I.8
Eerdekens, M.9
Swyzen, W.10
De Smedt, G.11
-
34
-
-
33645051491
-
Clinical trials for antipsychotic drugs: Design conventions, dilemmas and innovations
-
Stroup TS, Alves WM, Hamer RM, Lieberman JA. Clinical trials for antipsychotic drugs: design conventions, dilemmas and innovations. Nat Rev Drug Discov. 2006 ; 5: 133-146
-
(2006)
Nat Rev Drug Discov
, vol.5
, pp. 133-146
-
-
Stroup, T.S.1
Alves, W.M.2
Hamer, R.M.3
Lieberman, J.A.4
-
35
-
-
0030993030
-
Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: Results of an International Collaborative Trial
-
Tollefson GD, Beasley CM, Tran PV, et al. Olanzapine versus haloperidol in the treatment of schizophrenia, schizoaffective and schizophreniform disorders: results of an international collaborative trial. Am J Psychiatry. 1997 ; 154: 457-465 (Pubitemid 27147597)
-
(1997)
American Journal of Psychiatry
, vol.154
, Issue.4
, pp. 457-465
-
-
Tollefson, G.D.1
Beasley, C.M.2
Tran, P.V.3
Street, J.S.4
Krueger, J.A.5
Tamura, R.N.6
Graffeo, K.A.7
Thieme, M.E.8
-
36
-
-
0036159250
-
Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder
-
DOI 10.1176/appi.ajp.159.2.255
-
Volavka J, Czobor P, Sheitman B, et al. Clozapine, Olanzapine, Risperidone and Haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder. Am J Psychiatry. 2002 ; 159: 255-262 (Pubitemid 34126903)
-
(2002)
American Journal of Psychiatry
, vol.159
, Issue.2
, pp. 255-262
-
-
Volavka, J.1
Czobor, P.2
Sheitman, B.3
Lindenmayer, J.-P.4
Citrome, L.5
McEvoy, J.P.6
Cooper, T.B.7
Chakos, M.8
Lieberman, J.A.9
-
37
-
-
0026040246
-
Neuroleptics and the natural course of schizophrenia
-
Wyatt RJ. Neuroleptics and the natural course of schizophrenia. Schizophr Bull. 1991 ; 17: 325-351
-
(1991)
Schizophr Bull
, vol.17
, pp. 325-351
-
-
Wyatt, R.J.1
-
38
-
-
0018175277
-
A rating scale for mania: Reliability, validity and sensitivity
-
Young RC, Biggs JT, Ziegler VE, et al. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978 ; 133: 429-433
-
(1978)
Br J Psychiatry
, vol.133
, pp. 429-433
-
-
Young, R.C.1
Biggs, J.T.2
Ziegler, V.E.3
-
39
-
-
33747170572
-
Comparison of quetiapine and risperidone in the treatment of schizophrenia: A randomized, double-blind, flexible-dose, 8-week study
-
Zhong KX, Sweitzer DE, Hamer RM, et al. Comparison of quetiapine and risperidone in the treatment of schizophrenia: A randomized, double-blind, flexible-dose, 8-week study. J Clin Psychiatry. 2006 ; 67: 1093-1103 (Pubitemid 44230881)
-
(2006)
Journal of Clinical Psychiatry
, vol.67
, Issue.7
, pp. 1093-1103
-
-
Zhong, K.X.1
Sweitzer, D.E.2
Hamer, R.M.3
Lieberman, J.A.4
|